Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01245348 · ClinicalTrials.gov registry record
Relative Effectiveness of Schizophrenia Therapy Study
A clinical trial, sponsored by Medco Health Solutions.
- Completed
- Registry status
- 1,110
- Enrollment target
NCT01245348 is a clinical trial that has completed, run by Medco Health Solutions. The registered enrollment target is 1,110 participants.
The verdict
NCT01245348 has completed, sponsored by Medco Health Solutions.
- COMPLETED
- Registry status
- 1,110 participants
- Enrollment target
Study Summary
The purpose of this study is to validate that SULT4A1-1 status stratification improves responses to atypical antipsychotics in schizophrenia and to extend these findings into bipolar disorder.
Interventions
- GENETIC SULT4A1-1 genetic test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,110 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01245348
The ClinicalTrials.gov registry entry for NCT01245348 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medco Health Solutions, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SULT4A1-1 genetic test is the first listed.
NCT01245348 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01245348 about?
NCT01245348 is a clinical study titled "Relative Effectiveness of Schizophrenia Therapy Study". The purpose of this study is to validate that SULT4A1-1 status stratification improves responses to atypical antipsychotics in schizophrenia and to extend these findings into bipolar disorder.
What is the current status of trial NCT01245348?
This trial is currently completed. The enrollment target is 1,110 participants. The study started on 2010-12. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01245348?
The interventions under investigation include: SULT4A1-1 genetic test (GENETIC).
Who is sponsoring clinical trial NCT01245348?
This trial is sponsored by Medco Health Solutions, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.